Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer A Journal of Clinical Oncology podcast by Matthew D. Galsky, MD Originally published Jan. 25, 2016 This podcast reviews the International Bladder Cancer Group’s recommendations regarding definitions and endpoints for the development of non-muscle-invasive bladder cancer clinical trials. Read the associated abstract by Kamat, et al: Subscribe for more podcasts from JCO and JOP, and updates from ASCO Learn more about the Journal of Clinical Oncology: